Wolverine Trading, LLC Corvus Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.78 - $5.92 $25,098 - $83,472	14,100 New	14,100 $74,000
Q2 2023 Aug 23, 2023	BUY	$1.0 - $3.86 $15,400 - $59,444	15,400 New	15,400 $35,000
Q2 2022 Aug 15, 2022	SELL	$0.87 - $2.03 $12,354 - $28,825	-14,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.46 - $2.48 $20,732 - $35,216	14,200 New	14,200 $22,000
Q4 2021 Feb 14, 2022	SELL	$2.34 - $5.31 $72,540 - $164,610	-31,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.89 - $8.53 $58,590 - $264,430	31,000 New	31,000 $196,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.